Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...
Morning Overview on MSN
AI model cracks yeast DNA code to turbocharge protein drug output
MIT researchers have built an AI language model that learns the internal coding patterns of a yeast species widely used to manufacture protein-based drugs, then rewrites gene sequences to push protein ...
Researchers develop a single genome-editing strategy to treat multiple disorders caused by nonsense mutations, promising efficient and cost-effective therapies.
High-resolution imaging shows how MraZ breaks and deforms to attach to repeated DNA sequences, activating the gene cluster ...
Life runs on instructions you never see. Every cell reads DNA, turns that message into RNA, and then builds proteins that ...
A research team led by UAB researcher David Reverter has discovered the molecular mechanism that describes in detail the ...
MIT’s AI system boosts precision protein drug production, cutting development costs by learning the “language” of genetic sequences.
Researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with ...
GlobalData on MSN
RNA-targeting small molecules: a new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results